​

T2 Biosystems (TTOO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

TTOO Stock Forecast

T2 Biosystems (TTOO) stock forecast, based on 1 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $5.00 and a low of $5.00. This represents a 2172.73% increase from the last price of $0.22.

- $1 $2 $3 $4 $5 $6 High: $5 Avg: $5 Low: $5 Last Closed Price: $0.22

TTOO Stock Rating

T2 Biosystems stock's rating consensus is Hold, based on 1 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 0 Buy (0.00%), 1 Hold (100.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 1 0 1 Strong Sell Sell Hold Buy Strong Buy

TTOO Forecast vs Benchmarks

TypeNameUpside
StockT2 Biosystems2172.73%
SectorHealthcare Stocks 25.20%
IndustryDiagnostics & Research Stocks16.01%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$5.00
Last Closing Price$0.22$0.22$0.22
Upside/Downside--2172.73%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 24212--5
Oct, 24212--5
Sep, 24212--5
Aug, 24213--6
Jul, 242-3--5
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 30, 2024Kyle MiksonCanaccord Genuity$5.00$4.745.49%2172.73%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Jul 30, 2024Canaccord GenuityHoldHoldhold

Financial Forecast

EPS Forecast

$-3K $-2K $-2K $-1K $-500 $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.03K$-1.68K$-1.24K$-19.19-----
Avg Forecast$-1.99K$-1.62K$-1.24K$-18.57$-3.10$-1.19$-0.70$-0.46$-0.30
High Forecast$-1.99K$-1.62K$-1.24K$-18.57$-3.10$-1.19$-0.70$-0.46$-0.30
Low Forecast$-1.99K$-1.62K$-1.24K$-18.57$-3.10$-1.19$-0.70$-0.46$-0.30
Surprise %2.00%3.73%0.52%3.34%-----

Revenue Forecast

$5M $17M $29M $41M $53M $65M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$18.13M$28.06M$22.30M$7.19M-----
Avg Forecast$18.28M$27.52M$22.20M$7.90M$10.55M$23.13M$33.30M$45.70M$60.40M
High Forecast$18.28M$27.52M$22.20M$7.79M$10.55M$23.13M$33.30M$45.70M$60.40M
Low Forecast$18.28M$27.52M$22.20M$8.01M$10.55M$23.13M$33.30M$45.70M$60.40M
Surprise %-0.84%1.94%0.47%-8.95%-----

Net Income Forecast

$-6B $-4B $-3B $-2B $-1B $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-49.21M$-53.49M$-63.37M$-50.08M-----
Avg Forecast$-5.19B$-45.81M$-44.89M$-48.26M$-8.09M$-3.11M$-1.83M$-1.20M$-783.00K
High Forecast$-5.19B$-54.98M$-53.87M$-57.91M$-8.09M$-3.11M$-1.83M$-1.20M$-783.00K
Low Forecast$-5.19B$-36.65M$-35.92M$-38.61M$-8.09M$-3.11M$-1.83M$-1.20M$-783.00K
Surprise %-99.05%16.76%41.15%3.76%-----

TTOO Forecast FAQ

Is T2 Biosystems stock a buy?

T2 Biosystems stock has a consensus rating of Hold, based on 1 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 0 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that T2 Biosystems is a neutral investment for most analysts.

What is T2 Biosystems's price target?

T2 Biosystems's price target, set by 1 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $5 at the low end to $5 at the high end, suggesting a potential 2172.73% change from the previous close price of $0.22.

How does T2 Biosystems stock forecast compare to the average forecast of its sector, industry, and investment themes?

T2 Biosystems stock forecast shows a 2172.73% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the diagnostics & research stocks industry (16.01%).

What is the breakdown of analyst ratings for T2 Biosystems over the past three months?

  • November 2024: 40.00% Strong Buy, 20.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.
  • October 2024: 40.00% Strong Buy, 20.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.
  • September 2024: 40.00% Strong Buy, 20.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.

What is T2 Biosystems’s EPS forecast?

T2 Biosystems's average annual EPS forecast for its fiscal year ending in December is -3.1 for 2024, a -83.85% decrease from the reported $-19.19 in 2023. The prediction for 2025 is $-1.19, $-0.7 for 2026, $-0.46 for 2027, and $-0.3 for 2028.

What is T2 Biosystems’s revenue forecast?

T2 Biosystems's average annual revenue forecast for its fiscal year ending in December is $10.55M for 2024, a 46.69% increase from the reported $7.19M in 2023. The forecast for 2025 is $23.13M, $33.3M for 2026, $45.7M for 2027, and $60.4M for 2028.

What is T2 Biosystems’s net income forecast?

For its fiscal year ending in December, T2 Biosystems's average annual net income forecast is $-8.091M for 2024, reflecting a -83.84% decrease from the reported $-50.077M in 2023. The projection for 2025 is $-3.106M, $-1.827M for 2026, $-1.201M for 2027, and $-783K for 2028.